30 likes | 37 Views
Global Stem Cell Manufacturing Market Research Report: by Product (Stem Cell Lines, Instruments, Culture Media, Consumables), by Application (Research, Target Identification, Therapy, Cell & Tissue Banking), by End User (Hospitals, Others) - Forecast Till 2023
E N D
Market Research Future Stem Cell Manufacturing Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Stem Cell Manufacturing Market - Highlights The Global Stem Cell Manufacturing Market is anticipated to hold a market value of USD 10.8 billion in the year 2017 and is expected to grow at a CAGR of 6.6% during the forecast period. Stem cell manufacturing is a process wherein cells are extracted either from the bone marrow or the peripheral blood cells. These cells are then cultured in a culture dish containing nutrient media. Stem cells can be isolated from umbilical cord blood, placenta, amniotic sac & fluid, adipose tissue and menstrual blood. Growing investments & funding in stem cell-based research, increasing public awareness regarding therapeutic benefits of stem cell-based products and technological advancements related to stem cell manufacturing are expected to drive the growth in the market over the forecast period. For instance, in 2017, National Institutes of Health (NIH) invested USD 1.43 Billion approximately for stem cell research. However, ethical issues especially towards embryonic stem cell research and high costs involved can restrain the market growth over the assessment period. Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6942 Players Covered: Some of the prominent players in the global stem cell manufacturing market are Thermo Fisher Scientific, Merck KGaA, BD, Bio-Rad Laboratories, Inc., Lonza, AbbVie Inc., Bristol- Myers Squibb Company, GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, FUJIFILM Cellular Dynamics, Inc. (FCDI), American CryoStem Corporation, Takara Bio Inc., Miltenyi Biotec, STEMCELL Technologies Inc. and Others. Stem Cell Manufacturing Market – Segments The global stem cell manufacturing market has been segmented into product, application and end user.The market, on the basis of product, has been segmented into stem cell lines, instruments, culture media and consumables. Stem cell lines are further segmented into hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), induced pluripotent stem cell (iPSC), embryonic stem cell (ESC) and others. On the basis of products, instruments are further segmented into bioreactors, incubators, cell sorters and others. The global market, on the basis of application, has been segmented into research, target identification, therapy and cell & tissue banking. Therapy is further segmented into autologous and allogeneic. Cell and tissue banking segment is expected to hold the largest market share owing to increasing demand for cord blood stem cell banking and also rising awareness regarding stem cell preservation. Research segment is expected to be the fastest growing owing to increasing focus on stem cell research.The global stem cell manufacturing
Market Research Future market, by end user, has been segmented into hospitals, pharmaceutical & biotechnology companies, stem cell banks and others. Regional Wise Analysis: Geographically, the Americas is expected to dominate the global market owing to the high intensity of stem cell research in the region, rising number of stem cell transplants, well developed healthcare infrastructure and rising funding for stem cell research. According to a data published by the Lozier Institute in November 2017, about 20,000 adult stem cell transplants were performed in 2014 in the US. Europe is expected to hold the second largest position in the global market owing to the increasing awareness regarding stem cells and government funding for stem cell research. Asia-Pacific is expected to be the fastest growing market owing to the supportive regulatory framework for stem cell research in the region, increasing public as well as private investments and improving healthcare infrastructure. Moreover, the Middle East and Africa region is expected to account for the least market share in the global market. Browse Complete Report at https://www.marketresearchfuture.com/reports/stem-cell-manufacturing- market-6942 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com